Somavert Kit
Product Images NDC 0009-7188

Product Visual Gallery

This gallery contains 46 technical images submitted to the FDA as part of the official labeling for Somavert (NDC 0009-7188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Somavert 01)

An illustration of the amino acid sequence of the pegvisomant protein showing the linear arrangement of amino acids represented by their three-letter codes inside circles. Several sites are labeled with "PEG" indicating attachment points of polyethylene glycol (PEG) molecules along the sequence.*

FDA Label Image

Figure 1 (Somavert 02)

A multi-panel line graph showing the effects of SOMAVERT (pegvisomant) at doses of 10 mg/day, 15 mg/day, and 20 mg/day versus placebo over 12 weeks. Panels display concentrations of IGF-I, IGFBP-3, free IGF-I, and acid-labile subunit (ALS) in ng/mL on the y-axes, plotted against time in weeks on the x-axes. Data points include error bars and sample sizes for each treatment group are noted in the legend.*

FDA Label Image

Figure 2 (Somavert 03)

A vertical bar chart displaying the percentage of patients across four treatment groups: Placebo (10%), SOMAVERT 10 mg/day (39%), SOMAVERT 15 mg/day (75%), and SOMAVERT 20 mg/day (82%). The y-axis represents patient percentage from 0 to 100%.*

FDA Label Image

Figure 3 (Somavert 04)

A line graph illustrating percentage changes from baseline in IGF-I and GH levels over 12 weeks for placebo and three dosage groups (10 mg/d, 15 mg/d, 20 mg/d) of pegvisomant. IGF-I changes are shown with dashed lines on the left y-axis, while GH changes are depicted with solid lines on the right y-axis. The x-axis represents weeks of treatment from 0 to 12.*

FDA Label Image

Logo (Somavert 05)

FDA Label Image

Figure (Somavert 06)

FDA Label Image

Figure (Somavert 07)

An instructional illustration diagram labeling parts of a medication vial, safety needle, and syringe, including components such as vial cap, vial stopper, needle guard, needle cover, syringe cap, barrel, syringe collar, grip, and plunger rod.*

FDA Label Image

Figure (Somavert 08)

Instructional diagram showing recommended injection areas for SOMAVERT kit. Injection sites include the arms or lower back (back upper area of arms, for healthcare provider or caregiver only), the abdomen (at least 2 inches or 5 cm away from the belly button), and the thighs. The diagram depicts front and back body views with shaded regions identifying appropriate injection sites.*

FDA Label Image

Figure (Somavert 09)

An instructional illustration showing step 4: removing the vial cap from a medication vial. The illustration depicts hands holding the vial and lifting the cap off, with a blue arrow indicating the direction to remove the cap.*

FDA Label Image

Figure (Somavert 10)

An instructional illustration showing step 5 to remove the syringe cap. The image depicts a hand holding a syringe and another hand snapping off the cap from the syringe. The word 'snap' is shown with a visual effect indicating the action.*

FDA Label Image

Figure (Somavert 11)

An instructional illustration showing the step to attach a safety needle to a device. Two hands are depicted, one holding the device and the other the safety needle, with blue arrows indicating the attachment motion. This image is part of a kit for the drug SOMAVERT (pegvisomant).*

FDA Label Image

Figure (Somavert 12)

Instructional illustration showing step 7: removing the needle cover from a syringe attached to a vial. The hands demonstrate holding the vial and pulling off the protective cap from the needle, indicated by a blue arrow.*

FDA Label Image

Figure (Somavert 13)

An instructional illustration showing step 8 titled "Insert needle." The image depicts a hand holding a syringe with the needle being inserted downward into a vial, held steady by another hand, with a blue downward arrow indicating the direction of needle insertion.*

FDA Label Image

Figure (Somavert 14)

An instructional diagram showing step 9 in a process titled "Add liquid." It depicts a hand injecting liquid from a vial into a syringe, with a close-up view highlighting the vial's stopper and needle connection.*

FDA Label Image

Figure (Somavert 15)

An instructional illustration showing step 10 for using the SOMAVERT kit. It depicts a hand holding a vial labeled "Swirl vial," with a circular arrow underneath indicating a swirling motion to be performed on the vial.*

FDA Label Image

Figure (Somavert 16)

An instructional illustration showing a hand holding a vial, labeled as step 11 'Check medicine.' The image depicts proper handling of a medication vial, likely part of the preparation or administration process for the SOMAVERT pegvisomant injection kit by Pharmacia & Upjohn Company LLC.*

FDA Label Image

Figure (Somavert 17)

An instructional diagram showing step 12 in a process to reposition a needle on an injection pen. The illustration focuses on hands holding the pen, highlighting the needle area with a circular zoom for clarity.*

FDA Label Image

Figure (Somavert 18)

An instructional illustration showing the step to draw off dose from a vial using a syringe. The image depicts one hand holding the vial upside down and the other hand pulling the syringe plunger downwards, indicated by a blue arrow, as part of the dosage preparation process for the SOMAVERT kit.*

FDA Label Image

Figure (Somavert 19)

Instructional diagram showing step 14 of a procedure, titled 'Insert needle.' It depicts a hand holding a syringe with the needle pointing downward, ready to insert into the skin of an arm below. An arrow indicates the direction of needle insertion.*

FDA Label Image

Figure (Somavert 20)

An instructional illustration showing a hand injecting medicine using a syringe into the forearm of another hand. The image is labeled with the step number 15 and the instruction 'Inject medicine'.*

FDA Label Image

Figure (Somavert 21)

Step 16 from the SOMAVERT kit instructions illustrating how to make the needle safe by closing the needle cap until it clicks, as demonstrated by hands holding the syringe and cap.*

FDA Label Image

Figure (Somavert 22)

An instructional illustration showing a hand holding a syringe above a disposal container, demonstrating how to dispose of a medical needle or syringe safely. The image is labeled '17 Dispose' indicating a step in the disposal process, likely part of the SOMAVERT kit instructions.*

FDA Label Image

Figure (Somavert 23)

An instructional illustration showing a hand using a cotton ball or pad to clean or press on an injection site, labeled "After injection" with the number 18, indicating a step in a sequence.*

FDA Label Image

Logo (Somavert 24)

An instructional diagram showing three vials with varying amounts of foam and air bubbles. The first two vials indicate that tiny air bubbles are acceptable, while the third vial, highlighted with a magnified circle, shows a layer of foam which is marked as not acceptable.*

FDA Label Image

Principal Display Panel (1 mL Syringe Label)

FDA Label Image

Principal Display Panel (10 mg Vial Label)

Label for Sterile Water for Injection, USP, 1 mL single-dose vial used for reconstitution of SOMAVERT. The label states it contains no antimicrobial or other added substances, is sterile and nonpyrogenic. Manufactured by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer Inc, New York, NY. Includes NDC 0009-5936-01, lot/expiration placeholders, and Rx only designation.*

FDA Label Image

Principal Display Panel (10 mg Kit Carton)

Label for Somavert (pegvisomant) for injection, a prescription drug kit by Pharmacia & Upjohn Company LLC. The label shows a 10 mg per vial strength for subcutaneous use only. It specifies a single-dose vial with instructions to discard unused portions and is marked Rx only. The label includes manufacturing and licensing information for Pfizer.*

FDA Label Image

Principal Display Panel (15 mg Vial Label)

Somavert (pegvisomant) for injection 10 mg/vial packaging label by Pharmacia & Upjohn Company LLC, a Pfizer subsidiary. The label states it is for subcutaneous injection only, one single-dose vial per package, with instructions to discard unused portions. Includes contents description and manufacturer information with a barcode visible.*

FDA Label Image

Principal Display Panel (15 mg Kit Carton)

Packaging label for Somavert (pegvisomant) for injection, 10 mg per vial, manufactured by Pharmacia & Upjohn Company LLC, a Pfizer company. The carton is labeled for single-dose vials intended for subcutaneous injection only, with instructions to discard unused portions. The packaging includes the NDC 0009-5175-10 and notes that the carton contains ten single-dose vials of Somavert.*

FDA Label Image

Principal Display Panel (20 mg Vial Label)

The image shows the packaging label for SOMAVERT (pegvisomant) for injection, 10 mg per vial. It is a kit of single-dose vials intended for subcutaneous injection only. The packaging also notes that the kit contains prefilled syringes and needles, and includes storage and preparation instructions. The labeler is Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer Inc.*

FDA Label Image

Principal Display Panel (20 mg Kit Carton)

Packaging label for Somavert (pegvisomant) for injection, 15 mg per vial, supplied as a kit for subcutaneous use. Label indicates a single-dose vial with instructions to discard unused portion. Manufactured by Pharmacia & Upjohn Company LLC, the label also displays the Pfizer logo and includes product and lot information.*

FDA Label Image

Principal Display Panel (25 mg Vial Label)

Packaging label for Somavert (pegvisomant) for injection, 15 mg/vial, by Pharmacia & Upjohn Company LLC, a Pfizer Inc subsidiary. The label indicates the product is for subcutaneous injection only, supplied as a single-dose vial with a prefilled diluent syringe and safety needle. The packaging includes dosage and administration information and the NDC number 0009-7168-01.*

FDA Label Image

Principal Display Panel (25 mg Kit Carton)

The packaging label for Somavert (pegvisomant) for injection 15 mg/vial displays a white background with blue accent bars. The label indicates it is for subcutaneous injection only and consists of single-dose vials. It states to discard unused portions and mentions the contents of the intermediate carton as ten single-dose vials. The label shows the Pfizer logo and includes regulatory text and barcodes.*

FDA Label Image

Principal Display Panel (30 mg Vial Label)

Packaging label for SOMAVERT (pegvisomant) for injection 15 mg/vial single-dose vials kit by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer. The carton includes storage instructions, vial contents, and manufacturer details, highlighting it is for subcutaneous injection only.*

FDA Label Image

Principal Display Panel (30 mg Kit Carton)

SOMAVERT (pegvisomant) for injection 20 mg per vial kit label. Indicates prescription use for subcutaneous administration with one single-dose vial. Manufactured by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer. Includes lot and expiration information area and a barcode.*

FDA Label Image

Somavert 36

Packaging label for Somavert (pegvisomant) for injection 20 mg/vial, a kit for subcutaneous injection. It includes one single-dose vial and one prefilled syringe with 1 mL sterile water for injection. The label lists Pfizer as the manufacturer. The packaging specifies disposal instructions and storage information.*

FDA Label Image

Somavert 37

The packaging label for Somavert (pegvisomant) for injection, 20 mg/vial, intended for subcutaneous injection only. The kit contains single-dose vials, with instructions to discard unused portions. The label indicates the product is by Pfizer and includes the NDC 0009-5179-10. It also states the carton contains ten single-dose vials of Somavert.*

FDA Label Image

Somavert 38

The packaging label for Somavert (pegvisomant) for injection 20 mg/vial, a human prescription drug kit by Pharmacia & Upjohn Company LLC. The label indicates the product is for subcutaneous injection only and contains single-dose vials. The outer carton stores prefilled syringes containing diluent and vials, with detailed storage and preparation instructions included. The label also lists vial contents and manufacturer information.*

FDA Label Image

Somavert 39

Label for Somavert (pegvisomant) for injection, 25 mg per vial, intended for subcutaneous use. The label indicates a single-dose vial and instructs to discard unused portion. Manufactured by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer.*

FDA Label Image

Somavert 40

Packaging label for Somavert (pegvisomant) for injection, 25 mg per vial. This kit is for subcutaneous injection only and contains one single-dose vial and one prefilled syringe with 1 mL sterile water for injection, USP, and one 27 gauge 1/2 inch safety needle. Labeler is Pharmacia & Upjohn Company LLC, a Pfizer subsidiary. Made in Belgium.*

FDA Label Image

Somavert 41

Packaging label for Somavert (pegvisomant) for injection kit by Pharmacia & Upjohn Company LLC. The label indicates a strength of 25 mg per vial, for subcutaneous injection only, in single-dose vials. The package includes instructions to discard unused portions and states the contents as ten single-dose vials of Somavert. The Pfizer logo is present on the label.*

FDA Label Image

Somavert 42

Packaging label for Somavert (pegvisomant) for injection, 25 mg per vial. The label indicates it is for subcutaneous injection only and contains single-dose vials. Manufactured by Pharmacia & Upjohn Company LLC, a Pfizer subsidiary, with storage instructions and ingredient details listed. The package is a kit including vials and prefilled syringes.*

FDA Label Image

Somavert 43

Packaging label for Somavert (pegvisomant) injection, 30 mg per vial. The label specifies it is for subcutaneous use only and contains one single-dose vial. The product is labeled by Pharmacia & Upjohn Company LLC, a division of Pfizer. The label includes an NDC number and barcode.*

FDA Label Image

Somavert 44

Packaging label for Somavert (pegvisomant) for injection, 30 mg/vial, a kit by Pharmacia & Upjohn Company LLC, a Pfizer subsidiary. The label states it is for subcutaneous injection only, includes one single-dose vial, one diluent prefilled syringe with 1 mL sterile water for injection, and one 27 gauge safety needle. The label includes barcode and manufacturing information.*

FDA Label Image

Somavert 45

Box label for Somavert (pegvisomant) for injection 30 mg/vial, a kit for subcutaneous injection. The label notes it contains single-dose vials and instructs to discard unused portions. The labeler is Pharmacia & Upjohn Company LLC, and the product is marked Rx only. The packaging includes the Pfizer logo.*

FDA Label Image

Somavert 46

Packaging label for Somavert (pegvisomant) for injection, a 30 mg/vial kit for subcutaneous injection. The label shows it is manufactured by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer Inc. The label includes storage instructions, vial contents, and a barcode, indicating it contains single-dose vials and diluent syringes within the kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.